Orforglipron Dosing Guide: The Titration Schedule and What to Expect

Reading time
5 min
Published on
June 26, 2026
Updated on
June 26, 2026
Orforglipron Dosing Guide: The Titration Schedule and What to Expect

Orforglipron, sold as Foundayo, is a once-daily tablet you can take any time of day, with or without food or water. Dosing starts low at 0.8 mg and climbs in steps, with at least 30 days at each level. The path runs from 0.8 mg to 2.5 mg to 5.5 mg, with optional further increases to 9 mg, 14.5 mg, and 17.2 mg based on how you respond and how well you tolerate it. The maximum is 17.2 mg once daily. That slow climb is the whole point: it gives your gut time to adjust and keeps nausea in check. Now that orforglipron is FDA-approved, the schedule below reflects the actual label rather than trial protocols.

The titration schedule

Every patient follows the same starting path, then individualizes from there.

Step Once-daily dose Minimum time at this dose
Start 0.8 mg At least 30 days
Step 2 2.5 mg At least 30 days
Step 3 5.5 mg (first effective maintenance dose) At least 30 days
Optional steps 9 mg, then 14.5 mg, then 17.2 mg At least 30 days at each

Foundayo comes in six tablet strengths matching those steps: 0.8, 2.5, 5.5, 9, 14.5, and 17.2 mg. You take one tablet a day, never more, and you do not skip ahead. Each increase happens only after at least a month at the current dose.

Why the climb is so gradual

The first two doses, 0.8 mg and 2.5 mg, are mostly about building tolerance, not driving the scale down. Meaningful weight loss in the trials began around the 5.5 mg level. Higher doses produced more weight loss, but the trade-off was a higher chance of digestive side effects. Stepping up slowly lets your body adapt at each stage, which is why the protocol holds you at every level for a full month before considering the next. Rushing the schedule is the most reliable way to trigger severe nausea or vomiting.

Finding your maintenance dose

There’s no single right dose. Maintenance for most people lands somewhere between 5.5 mg and 17.2 mg, and the best dose is the one that balances good results with side effects you can tolerate over the long haul. Chasing the maximum when a lower dose is already working well rarely adds much and can cost you in quality of life. Consider a scenario where someone reaches 9 mg, is losing weight steadily, and feels fine. There may be no reason to push higher. Your provider sets the target based on your response, not a fixed endpoint.

Taking it correctly

Orforglipron’s biggest practical advantage over other oral GLP-1 options is flexibility. Unlike Rybelsus or oral Wegovy, which require an empty stomach and a 30-minute wait, orforglipron has no food or water restrictions and no fixed timing. Most people pick a consistent daily anchor, like a morning routine, to avoid missed doses.

A few specifics matter. If you miss one to six days, you resume your current dose, and mild digestive symptoms may briefly return as your body readjusts. If you miss seven or more days, the dose is restarted at 0.8 mg and the schedule begins again, because jumping back to a higher dose after a gap raises the risk of severe nausea. Orforglipron is processed partly through the CYP3A4 enzyme pathway, so if you take a strong inhibitor of that pathway, the dose is capped at 9 mg. Always share your full medication list with your prescriber before starting.

What to expect along the way

In the obesity trials, weight loss tended to begin within the first month and was greatest over roughly the first 36 weeks, then continued at a slower, steadier pace. The early weeks at 0.8 mg and 2.5 mg may not move the scale much, and that’s expected. The work of the medication ramps up as you reach effective doses. Side effects, when they appear, track with each step up and usually settle within a couple of weeks at a stable dose.

If side effects make a step difficult, the answer is to slow down rather than power through. Holding at your current dose for an extra month, or stepping back temporarily, is a normal part of the process.

The bottom line

Orforglipron dosing is a deliberate, multi-month climb designed to build tolerance while getting you to a dose that works. Start low, hold at each level, step up only if tolerated, and settle wherever results and comfort meet. The schedule is the same for everyone at the start, but where you land is personal.

For help handling the adjustment period, our orforglipron side effects guide covers what’s normal and what isn’t. If you’ve titrated other GLP-1 drugs before, you’ll recognize the rhythm from our guides to the starting dose of tirzepatide and the Ozempic starting dose. To see whether a personalized weight-loss program fits your situation, you can take the free TrimRx assessment quiz.

This article is for educational purposes only and is not medical advice. Dosing decisions belong with your licensed healthcare provider, who will set your schedule and target dose based on your response and tolerance. Do not start, stop, or adjust orforglipron on your own.

Transforming Lives, One Step at a Time

Patients on TrimRx can maintain the WEIGHT OFF
Start Your Treatment Now!

Keep reading

5 min read

Orforglipron Side Effects: What to Expect and How to Manage Them

Orforglipron, sold under the brand name Foundayo, has a side effect profile that looks a lot like other GLP-1 medications. The most common reactions…

4 min read

Foundayo (Orforglipron): The FDA-Approved Weight Loss Pill

Orforglipron is now approved and on the market under the brand name Foundayo. The FDA approved it on April 1, 2026, for adults with…

5 min read

Survodutide vs CagriSema: Two Investigational Obesity Drugs Compared

Survodutide and CagriSema are both investigational obesity drugs, but they come from different companies and use different hormone combinations. Survodutide (Boehringer Ingelheim and Zealand…

Stay on Track

Join our community and receive:
Expert tips on maximizing your GLP-1 treatment.
Exclusive discounts on your next order.
Updates on the latest weight-loss breakthroughs.